Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

INBX

Inhibrx Biosciences (INBX)

Inhibrx Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBX
DateTimeSourceHeadlineSymbolCompany
02/14/20226:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INBXInhibrx Biosciences Inc
02/14/20226:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INBXInhibrx Biosciences Inc
02/14/20226:01AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INBXInhibrx Biosciences Inc
01/25/20226:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
01/05/202212:35AMTipRanksAnalysts’ Top Healthcare Picks: Enanta Pharmaceuticals (ENTA), Crinetics Pharmaceuticals (CRNX)NASDAQ:INBXInhibrx Biosciences Inc
01/04/20224:43PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
01/04/20224:05PMPR Newswire (US)Inhibrx Announces Initial Phase 1 Dose Escalation Results for INBRX-106, a Novel Hexavalent OX40 Agonist, in Combination with Keytruda® (Pembrolizumab) Along with Updated Single Agent DataNASDAQ:INBXInhibrx Biosciences Inc
12/01/20214:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
12/01/20214:05PMPR Newswire (US)Inhibrx Receives FDA Orphan-Drug Designation for INBRX-109 in ChondrosarcomaNASDAQ:INBXInhibrx Biosciences Inc
11/09/20214:44PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
11/09/20214:05PMPR Newswire (US)Inhibrx Reports Third Quarter 2021 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
11/03/20218:00AMPR Newswire (US)Inhibrx Announces Presentations at SITC 2021NASDAQ:INBXInhibrx Biosciences Inc
11/01/20215:51PMPR Newswire (US)Inhibrx Announces Participation in Upcoming Scientific and Investor ConferencesNASDAQ:INBXInhibrx Biosciences Inc
10/29/20215:28PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INBXInhibrx Biosciences Inc
10/28/20218:30AMPR Newswire (US)Inhibrx Strengthens Leadership Team with Three Key Executive Hires and Announces Appointment of Kristiina Vuori, M.D., Ph.D. to its Board of DirectorsNASDAQ:INBXInhibrx Biosciences Inc
10/12/20218:32AMInvestorsHub NewsWireINBRX-101 Shows Favorable Safety Profile in Patients with Alpha-1 Antitrypsin Deficiency and Demonstrates the Potential to Achieve Normal Alpha-1 Antitrypsin Levels with Monthly DosingNASDAQ:INBXInhibrx Biosciences Inc
10/12/20217:51AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
10/12/20217:30AMPR Newswire (US)INBRX-101 Shows Favorable Safety Profile in Patients with Alpha-1 Antitrypsin Deficiency and Demonstrates the Potential to Achieve Normal Alpha-1 Antitrypsin Levels with Monthly DosingNASDAQ:INBXInhibrx Biosciences Inc
10/11/20214:05PMPR Newswire (US)Inhibrx To Host Webcast Presentation of Interim Results from the Phase 1 Trial of INBRX-101, its Recombinant Human AAT-Fc Protein for the Treatment of Alpha-1 Antitrypsin DeficiencyNASDAQ:INBXInhibrx Biosciences Inc
09/13/20214:30PMPR Newswire (US)Inhibrx Announces Participation in Upcoming Investor ConferenceNASDAQ:INBXInhibrx Biosciences Inc
09/03/20214:34PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
08/09/20214:38PMPR Newswire (US)Inhibrx Reports Second Quarter 2021 Financial ResultsNASDAQ:INBXInhibrx Biosciences Inc
08/09/20214:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
08/09/20214:09PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INBXInhibrx Biosciences Inc
06/22/20217:30AMInvestorsHub NewsWireInhibrx Initiates a Potential Registration-Enabling Phase 2 Study of INBRX-109 in Conventional Chondrosarcoma Patients, ..ContNASDAQ:INBXInhibrx Biosciences Inc
06/21/20214:05PMPR Newswire (US)Inhibrx Initiates a Potential Registration-Enabling Phase 2 Study of INBRX-109 in Conventional Chondrosarcoma Patients, Updat...NASDAQ:INBXInhibrx Biosciences Inc
06/08/20215:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
06/08/20215:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
05/17/20214:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INBXInhibrx Biosciences Inc
05/17/20214:05PMPR Newswire (US)Inhibrx Announces Participation in Upcoming Investor ConferencesNASDAQ:INBXInhibrx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:INBX